According to FutureWise analysis the Clinical Trials Imaging Techniques Market in 2023 was US$ 1.3 billion, and is expected to reach US$ 2.43 billion by 2031 at a CAGR of 8.10%. The demand for precise, non-invasive biomarkers in oncology, neurology, and cardiovascular trials is driving growth in the field. Advanced imaging techniques like MRI, PET, and CT are improving trial accuracy, enhancing patient safety, and ensuring regulatory compliance globally.
A clinical trial is a prospective research study which tests a new treatment or novel way of using existing treatment to see if it will be a better way to prevent or treat and screen for diagnose or treat a disease. During these study volunteers (research subjects either humans or animals) will undergo various imaging techniques to see the effect of novel drug /treatment on disease part of interest. Presently various imaging techniques are emerging to gain the metabolic and functional information from the molecular level. So, imaging has a specific central role in evaluating the impact of devices and drugs in clinical trials.
Imaging technologies have rapidly gained traction over the past decades due to increasing clinical trial applications. Traction is further gained by increasing the number of clinical trials due to increasing R D investments led to robust growth of global clinical trials imaging techniques market. Imaging techniques have a wide range of applications in assessing treatment response for medical interventions. Additionally, they also offer metabolic and functional information through molecular imaging techniques. All these factors led to the potential growth of clinical trial imaging techniques market. Molecular imaging also provides treatment follow-up information and decreases medical errors during the clinical trials. These features led to increasing applicability of imaging techniques in clinical trials and boosted the growth of the market.
Global Oncology information system market is dominated by North America and Europe due to high capital investment in research. Further, they are expected to remain dominant throughout the forecast period. Asia Pacific is expected to register a fast growth rate during the forecast period due to an increase in R D activities. Latin America and Rest of World Clinical Trials Imaging Techniques market is expected to remain slow-growing regions due to lack of R D investments.